Sign In
Samples
/
Keytruda
Oncology
Keytruda
pembrolizumab
Manufacturer
Merck
Indication
PD-1 inhibitor for multiple cancer types
Restrictions:
Oncology specialty required. Administered in clinical settings.
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with Merck
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from Merck
View all
Gardasil 9
human papillomavirus 9-valent vaccine
Vaccines
Januvia
sitagliptin
Diabetes
Janumet
sitagliptin/metformin
Diabetes
Singulair
montelukast
Respiratory
Nasonex
mometasone furoate
Respiratory
More Oncology Samples
View all
Tecentriq
atezolizumab
Genentech (Roche)
Darzalex
daratumumab
Janssen (J&J)
Tagrisso
osimertinib
AstraZeneca
Herceptin
trastuzumab
Genentech (Roche)
Ibrance
palbociclib
Pfizer
Avastin
bevacizumab
Genentech (Roche)
Popular Samples
Browse all
Mounjaro
tirzepatide
Eli Lilly
Diabetes
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Zepbound
tirzepatide
Eli Lilly
Obesity
Eliquis
apixaban
Pfizer
Cardiovascular
Dupixent
dupilumab
Sanofi
Immunology
Jardiance
empagliflozin
Eli Lilly
Diabetes
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas